{"id":1194405,"date":"2022-02-17T13:18:40","date_gmt":"2022-02-17T12:18:40","guid":{"rendered":"https:\/\/frezzapartners.com\/?p=1194405"},"modified":"2022-02-17T13:41:45","modified_gmt":"2022-02-17T12:41:45","slug":"msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici","status":"publish","type":"post","link":"https:\/\/frezzapartners.com\/en\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\/","title":{"rendered":"Msd e Curve Therapeutics: accordo per la scoperta di nuovi target terapeutici"},"content":{"rendered":"<p>&nbsp;<\/p>\n<p>Curve Therapeutics (Curve), azienda biotecnologica privata, ha annunciato una nuova collaborazione di ricerca globale con Msd per scoprire e convalidare fino a cinque nuovi obiettivi terapeutici utilizzando la sua piattaforma Microcycle<sup>\u00ae<\/sup>.<\/p>\n<p>La piattaforma di Curve favorisce la scoperta diretta di molecole biologicamente attive contro obiettivi difficili da perseguire con gli usuali metodi di scoperta di farmaci.<\/p>\n<p>Curve in seguito a questo accordo ricever\u00e0 un pagamento anticipato a cui faranno seguito obiettivi di ricerca, sviluppo e commercializzazione per un valore di 1,7 miliardi di dollari, qualora tutti e cinque i programmi di ricerca avranno esito positivo.<\/p>\n<p>Simon Kerry, PhD, MBA, amministratore delegato di Curve, ha affermato: &#8220;Questa collaborazione \u00e8 una pietra miliare per Curve e un&#8217;importante conferma della nostra innovativa piattaforma di scoperta di farmaci. Lavorare con Msd su bersagli terapeutici selezionati completer\u00e0 i programmi interni di scoperta e sviluppo dei farmaci di Curve&#8221;.<\/p>\n<p>Per leggere il comunicato di Curve Therapeutics <a href=\"https:\/\/www.curvetx.com\/curve-therapeutics-announces-collaboration-with-msd-for-next-generation-drug-discovery-platform\/\">qui<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; Curve Therapeutics (Curve), azienda biotecnologica privata, ha annunciato una nuova collaborazione di ricerca globale con Msd per scoprire e convalidare fino a cinque nuovi obiettivi terapeutici utilizzando la sua piattaforma Microcycle\u00ae. La piattaforma di Curve favorisce la scoperta diretta di molecole biologicamente attive contro obiettivi difficili da perseguire con gli usuali metodi di scoperta di farmaci. Curve in seguito a questo accordo ricever\u00e0 un pagamento anticipato a cui faranno seguito obiettivi di ricerca, sviluppo e commercializzazione per un valore&#8230;<\/p>\n","protected":false},"author":297440,"featured_media":1194412,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[141],"tags":[3400],"class_list":["post-1194405","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-biotecnologie-accordo"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Msd e Curve Therapeutics: accordo per la scoperta di nuovi target terapeutici - Frezza Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/frezzapartners.com\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Msd e Curve Therapeutics: accordo per la scoperta di nuovi target terapeutici - Frezza Partners\" \/>\n<meta property=\"og:description\" content=\"&nbsp; Curve Therapeutics (Curve), azienda biotecnologica privata, ha annunciato una nuova collaborazione di ricerca globale con Msd per scoprire e convalidare fino a cinque nuovi obiettivi terapeutici utilizzando la sua piattaforma Microcycle\u00ae. La piattaforma di Curve favorisce la scoperta diretta di molecole biologicamente attive contro obiettivi difficili da perseguire con gli usuali metodi di scoperta di farmaci. Curve in seguito a questo accordo ricever\u00e0 un pagamento anticipato a cui faranno seguito obiettivi di ricerca, sviluppo e commercializzazione per un valore...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/frezzapartners.com\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\/\" \/>\n<meta property=\"og:site_name\" content=\"Frezza Partners\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-17T12:18:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-17T12:41:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/frezzapartners.com\/wp-content\/uploads\/2022\/02\/technology-g197bd1c77_1920.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1281\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Frezza Partners\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Frezza Partners\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\\\/\"},\"author\":{\"name\":\"Frezza Partners\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"headline\":\"Msd e Curve Therapeutics: accordo per la scoperta di nuovi target terapeutici\",\"datePublished\":\"2022-02-17T12:18:40+00:00\",\"dateModified\":\"2022-02-17T12:41:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\\\/\"},\"wordCount\":163,\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/technology-g197bd1c77_1920.jpg\",\"keywords\":[\"#biotecnologie #accordo\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\\\/\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\\\/\",\"name\":\"Msd e Curve Therapeutics: accordo per la scoperta di nuovi target terapeutici - Frezza Partners\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/technology-g197bd1c77_1920.jpg\",\"datePublished\":\"2022-02-17T12:18:40+00:00\",\"dateModified\":\"2022-02-17T12:41:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/frezzapartners.com\\\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\\\/#primaryimage\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/technology-g197bd1c77_1920.jpg\",\"contentUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/technology-g197bd1c77_1920.jpg\",\"width\":1920,\"height\":1281},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/frezzapartners.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Msd e Curve Therapeutics: accordo per la scoperta di nuovi target terapeutici\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/\",\"name\":\"Frezza Partners\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/frezzapartners.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\",\"name\":\"Frezza Partners\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/en\\\/author\\\/fr3zz4partn3rs\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Msd e Curve Therapeutics: accordo per la scoperta di nuovi target terapeutici - Frezza Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/frezzapartners.com\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\/","og_locale":"en_US","og_type":"article","og_title":"Msd e Curve Therapeutics: accordo per la scoperta di nuovi target terapeutici - Frezza Partners","og_description":"&nbsp; Curve Therapeutics (Curve), azienda biotecnologica privata, ha annunciato una nuova collaborazione di ricerca globale con Msd per scoprire e convalidare fino a cinque nuovi obiettivi terapeutici utilizzando la sua piattaforma Microcycle\u00ae. La piattaforma di Curve favorisce la scoperta diretta di molecole biologicamente attive contro obiettivi difficili da perseguire con gli usuali metodi di scoperta di farmaci. Curve in seguito a questo accordo ricever\u00e0 un pagamento anticipato a cui faranno seguito obiettivi di ricerca, sviluppo e commercializzazione per un valore...","og_url":"https:\/\/frezzapartners.com\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\/","og_site_name":"Frezza Partners","article_published_time":"2022-02-17T12:18:40+00:00","article_modified_time":"2022-02-17T12:41:45+00:00","og_image":[{"width":1920,"height":1281,"url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2022\/02\/technology-g197bd1c77_1920.jpg","type":"image\/jpeg"}],"author":"Frezza Partners","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Frezza Partners","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/frezzapartners.com\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\/#article","isPartOf":{"@id":"https:\/\/frezzapartners.com\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\/"},"author":{"name":"Frezza Partners","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"headline":"Msd e Curve Therapeutics: accordo per la scoperta di nuovi target terapeutici","datePublished":"2022-02-17T12:18:40+00:00","dateModified":"2022-02-17T12:41:45+00:00","mainEntityOfPage":{"@id":"https:\/\/frezzapartners.com\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\/"},"wordCount":163,"image":{"@id":"https:\/\/frezzapartners.com\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2022\/02\/technology-g197bd1c77_1920.jpg","keywords":["#biotecnologie #accordo"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/frezzapartners.com\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\/","url":"https:\/\/frezzapartners.com\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\/","name":"Msd e Curve Therapeutics: accordo per la scoperta di nuovi target terapeutici - Frezza Partners","isPartOf":{"@id":"https:\/\/frezzapartners.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/frezzapartners.com\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\/#primaryimage"},"image":{"@id":"https:\/\/frezzapartners.com\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2022\/02\/technology-g197bd1c77_1920.jpg","datePublished":"2022-02-17T12:18:40+00:00","dateModified":"2022-02-17T12:41:45+00:00","author":{"@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"breadcrumb":{"@id":"https:\/\/frezzapartners.com\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/frezzapartners.com\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/frezzapartners.com\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\/#primaryimage","url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2022\/02\/technology-g197bd1c77_1920.jpg","contentUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2022\/02\/technology-g197bd1c77_1920.jpg","width":1920,"height":1281},{"@type":"BreadcrumbList","@id":"https:\/\/frezzapartners.com\/msd-e-curve-therapeutics-nuovo-accordo-per-la-scoperta-di-nuovi-target-terapeutici\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/frezzapartners.com\/"},{"@type":"ListItem","position":2,"name":"Msd e Curve Therapeutics: accordo per la scoperta di nuovi target terapeutici"}]},{"@type":"WebSite","@id":"https:\/\/frezzapartners.com\/#website","url":"https:\/\/frezzapartners.com\/","name":"Frezza Partners","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/frezzapartners.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0","name":"Frezza Partners","url":"https:\/\/frezzapartners.com\/en\/author\/fr3zz4partn3rs\/"}]}},"_links":{"self":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/1194405","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/users\/297440"}],"replies":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/comments?post=1194405"}],"version-history":[{"count":0,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/1194405\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media\/1194412"}],"wp:attachment":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media?parent=1194405"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/categories?post=1194405"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/tags?post=1194405"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}